TERRY TOO SOON
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 08 Aug 2024)
What this means for you
Registered since 18 Jul 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86982512
- Registration number
- 5247372
- Mark type
- Stylized text
- Filed
- 15 Apr 2015
- Published for opposition
- 22 Mar 2016
- Registered
- 18 Jul 2017
- Attorney of record
- Janie L. Thompson
Goods and services
- Class 016 — Paper goods and printed matter: NEWSLETTERS, PAMPHLETS AND BOOKS DEALING WITH PRECOCIOUS PUBERTY
Owner
- AbbVie Endocrine Inc., North Chicago, IL, US
- AbbVie Endocrine Inc., North Chicago, IL, US
- AbbVie Endocrine Inc., North Chicago, IL, US
Prosecution history
- 08 Aug 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 08 Aug 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 03 Aug 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 Jan 2024 — TEAS SECTION 8 & 15 RECEIVED
- 18 Jul 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 18 Jul 2017 — REGISTERED-PRINCIPAL REGISTER
- 14 Jun 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Jun 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Jun 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 16 May 2017 — USE AMENDMENT FILED
- 07 Jun 2017 — DIVISIONAL PROCESSING COMPLETE
- 16 May 2017 — DIVISIONAL REQUEST RECEIVED
- 05 Jun 2017 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 16 May 2017 — TEAS REQUEST TO DIVIDE RECEIVED
- 16 May 2017 — TEAS STATEMENT OF USE RECEIVED